ANDA 88205, held by Pliva. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 88205 (Cyproheptadine Hydrochloride), held by Pliva, was first approved by FDA on Jul 26, 1983, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 26, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride4MG ยท tablet;oral | Cyproheptadine Hydrochloride | Discontinued |
| Sep 5, 2002 | Supplement 16Labeling | Approved | None posted |
| May 6, 2002 | Supplement 12Manufacturing | Approved | None posted |
| May 6, 2002 | Supplement 14Manufacturing | Approved | None posted |
| May 6, 2002 | Supplement 15Manufacturing | Approved | None posted |
| Oct 1, 2001 | Supplement 11Labeling | Approved | None posted |
| Jul 7, 2000 | Supplement 10Manufacturing | Approved | None posted |
| May 11, 1994 | Supplement 8Manufacturing | Approved | None posted |
| Jun 7, 1988 | Supplement 7Manufacturing | Approved | None posted |
| Aug 5, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Jun 19, 1985 | Supplement 1Manufacturing | Approved | None posted |
| Jun 19, 1985 | Supplement 2Manufacturing | Approved | None posted |
| Jun 19, 1985 | Supplement 3Manufacturing | Approved | None posted |
| Jul 26, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters